NeoGenomics, Inc. - Common Stock (NQ:NEO)

16.88 +0.35 (+2.12%)

Streaming Delayed Price Updated: 12:30 PM EDT, Aug 21, 2026 Add to My Watchlist

Price and Volume

Volume	383,749
Open	16.60
Bid (Size)	16.85 (400)
Ask (Size)	16.89 (300)
Prev. Close	16.53
Today's Range	16.21 - 16.98
52wk Range	5.940 - 16.92
Shares Outstanding	122,816,314
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Unprofitable Stocks Walking a Fine Line

Today 0:38 EDT

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...

Via StockStory

3 Stocks Under $50 with Open Questions

August 06, 2026

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...

Via StockStory

Performance

YTD	+43.5%	+43.5%
1 Month	+16.8%	+16.8%
3 Month	+85.3%	+85.3%
6 Month	+68.6%	+68.6%
1 Year	+176.7%	+176.7%

More News

3 Healthcare Stocks with Questionable Fundamentals

August 03, 2026

Via StockStory

Why NeoGenomics (NEO) Stock Is Up Today

July 29, 2026

Via StockStory

NeoGenomics (NASDAQ:NEO): Quality Stock After Q2 Earnings Beat and Raised Guidance ↗

July 28, 2026

Via Chartmill

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

July 29, 2026

Via StockStory

NeoGenomics Q2 Earnings Call Highlights ↗

July 28, 2026

Via MarketBeat

NeoGenomics’s (NASDAQ:NEO) Q2 CY2026: Beats On Revenue

July 28, 2026

Via StockStory

NeoGenomics Reports Second Quarter 2026 Results

July 28, 2026

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics (NEO) Q2 Earnings Report Preview: What To Look For

July 26, 2026

Via StockStory

1 Momentum Stock with Solid Fundamentals and 2 We Avoid

July 23, 2026

Via StockStory

NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS

July 20, 2026

From NeoGenomics, Inc.

Via Business Wire

3 Small-Cap Stocks with Questionable Fundamentals

July 15, 2026

Via StockStory

NeoGenomics (NEO) Stock Trades Up, Here Is Why

July 09, 2026

Via StockStory

NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer

July 09, 2026

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026

July 07, 2026

From NeoGenomics, Inc.

Via Business Wire

A Look Back at Testing & Diagnostics Services Stocks’ Q1 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack

June 25, 2026

Via StockStory

NeoGenomics Appoints Carolyn Starrett to its Board of Directors

June 25, 2026

From NeoGenomics, Inc.

Via Business Wire

1 Unprofitable Stock for Long-Term Investors and 2 Facing Headwinds

June 19, 2026

Via StockStory

NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes

June 17, 2026

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes

June 15, 2026

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics to Present New Research at ASCO Annual Meeting 2026

May 26, 2026

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics to Participate in Upcoming Investor Conferences

May 15, 2026

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know

May 13, 2026

Via StockStory

3 Russell 2000 Stocks We’re Skeptical Of

May 08, 2026

Via StockStory

Frequently Asked Questions

Is NeoGenomics, Inc. - Common Stock publicly traded?

Yes, NeoGenomics, Inc. - Common Stock is publicly traded.

What exchange does NeoGenomics, Inc. - Common Stock trade on?

NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for NeoGenomics, Inc. - Common Stock?

The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market

What is the current price of NeoGenomics, Inc. - Common Stock?

The current price of NeoGenomics, Inc. - Common Stock is 16.88

When was NeoGenomics, Inc. - Common Stock last traded?

The last trade of NeoGenomics, Inc. - Common Stock was at 08/21/26 12:30 PM ET

What is the market capitalization of NeoGenomics, Inc. - Common Stock?

The market capitalization of NeoGenomics, Inc. - Common Stock is 2.07B

How many shares of NeoGenomics, Inc. - Common Stock are outstanding?

NeoGenomics, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.